Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1970259329;59330;59331 chr2:178593015;178593014;178593013chr2:179457742;179457741;179457740
N2AB1806154406;54407;54408 chr2:178593015;178593014;178593013chr2:179457742;179457741;179457740
N2A1713451625;51626;51627 chr2:178593015;178593014;178593013chr2:179457742;179457741;179457740
N2B1063732134;32135;32136 chr2:178593015;178593014;178593013chr2:179457742;179457741;179457740
Novex-11076232509;32510;32511 chr2:178593015;178593014;178593013chr2:179457742;179457741;179457740
Novex-21082932710;32711;32712 chr2:178593015;178593014;178593013chr2:179457742;179457741;179457740
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Q
  • RefSeq wild type transcript codon: CAG
  • RefSeq wild type template codon: GTC
  • Domain: Fn3-31
  • Domain position: 23
  • Structural Position: 25
  • Q(SASA): 0.3691
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Q/H rs1380151837 -0.621 0.006 D 0.196 0.127 0.167679373172 gnomAD-2.1.1 8.05E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.78E-05 0
Q/H rs1380151837 -0.621 0.006 D 0.196 0.127 0.167679373172 gnomAD-4.0.0 3.18388E-06 None None None None N None 0 0 None 0 0 None 0 0 5.71853E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Q/A 0.249 likely_benign 0.2543 benign -0.512 Destabilizing 0.495 N 0.314 neutral None None None None N
Q/C 0.688 likely_pathogenic 0.6933 pathogenic 0.145 Stabilizing 0.995 D 0.507 neutral None None None None N
Q/D 0.5771 likely_pathogenic 0.5217 ambiguous -0.431 Destabilizing 0.329 N 0.313 neutral None None None None N
Q/E 0.1351 likely_benign 0.1133 benign -0.389 Destabilizing 0.01 N 0.127 neutral N 0.443711684 None None N
Q/F 0.6481 likely_pathogenic 0.6809 pathogenic -0.318 Destabilizing 0.893 D 0.54 neutral None None None None N
Q/G 0.3324 likely_benign 0.3011 benign -0.82 Destabilizing 0.665 D 0.437 neutral None None None None N
Q/H 0.2661 likely_benign 0.2593 benign -0.742 Destabilizing 0.006 N 0.196 neutral D 0.524503484 None None N
Q/I 0.3364 likely_benign 0.3635 ambiguous 0.251 Stabilizing 0.543 D 0.563 neutral None None None None N
Q/K 0.1469 likely_benign 0.1116 benign -0.395 Destabilizing 0.01 N 0.122 neutral N 0.417295874 None None N
Q/L 0.1235 likely_benign 0.1246 benign 0.251 Stabilizing 0.002 N 0.293 neutral N 0.492295065 None None N
Q/M 0.303 likely_benign 0.3278 benign 0.647 Stabilizing 0.893 D 0.449 neutral None None None None N
Q/N 0.3197 likely_benign 0.3275 benign -0.749 Destabilizing 0.704 D 0.297 neutral None None None None N
Q/P 0.5856 likely_pathogenic 0.515 ambiguous 0.027 Stabilizing 0.917 D 0.543 neutral N 0.518750948 None None N
Q/R 0.1876 likely_benign 0.1541 benign -0.267 Destabilizing 0.023 N 0.123 neutral N 0.431150606 None None N
Q/S 0.2583 likely_benign 0.2791 benign -0.776 Destabilizing 0.495 N 0.304 neutral None None None None N
Q/T 0.2299 likely_benign 0.2421 benign -0.563 Destabilizing 0.828 D 0.427 neutral None None None None N
Q/V 0.2428 likely_benign 0.2542 benign 0.027 Stabilizing 0.543 D 0.457 neutral None None None None N
Q/W 0.6961 likely_pathogenic 0.6812 pathogenic -0.244 Destabilizing 0.995 D 0.521 neutral None None None None N
Q/Y 0.4749 ambiguous 0.4733 ambiguous -0.048 Destabilizing 0.893 D 0.612 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.